The major indices begin the session with small gains. The S&P 500 is up 0.1%, the Nasdaq Composite is up 0.1%, and the Dow Jones Industrial Average is up 0.3%. Following are the top two notable movers. Sorrento Therapeutics (NASDAQ:SRNE) stock is up 4% after the company announces publication of significant positive pivotal trial results …
SRNE news
Sorrento Therapeutics Inc. (NASDAQ:SRNE) Stock Comes Back Strongly: How Far Can it Go?
Sorrento Therapeutics Inc. (NASDAQ:SRNE) jumped 8.5% after announcing establishing a subsidiary in Mexico, Sorrento Therapeutics Mexico. The subsidiary will support the clinical development and enrolment of several COVID-19 related products the company will be developing and commercializing in Latin America and Mexico. In addition, Sorrento Mexico will be responsible for all the company’s activities in …
Sorrento Therapeutics (NASDAQ:SRNE) Stock Sees High Volatility: Better To Stay Away?
Sorrento Therapeutics (NASDAQ:SRNE) shares are down by 9% from the beginning of the week as the firm came out with U.S. Food and Drug Administration clearedResiniferatoxin (RTX). RTX is a non-opioid medication which targets treating of knee pain from osteoarthritis, for a Phase 2 clinical trial. Sorrento has myriad Covid-19 treatment and diagnostics which have …
Sorrento Therapeutics (SRNE) stock Move Back To $10 On Profit Booking
On Thursday, the Sorrento Therapeutics (NASDAQ:SRNE) stock had been a notable mover, having gone up by 12% but this morning the stock has corrected sharply and declined by 8.50% at the time of writing. In this regard, it is perhaps necessary for investors to figure out why the stock actually rallied so strongly yesterday. There …
Continue reading “Sorrento Therapeutics (SRNE) stock Move Back To $10 On Profit Booking”